Formulation Compatibility of Myristyl Nicotinate with Drugs Used to Treat Dermatological Conditions Involving an Impaired Skin Barrier
Authors:
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 33 (11) , 1176-1182
Abstract
A number of dermatology conditions including skin photodamage, atopic dermatitis, and rosacea involve skin barrier impairment and first line therapies for these conditions including retinoids and steroids further impair skin barrier function. We have evaluated the compatibility of myristyl nicotinate, an agent that enhances skin barrier function, with drugs used to treat conditions where skin barrier impairment is present including photodamage (retinoic acid), atopic dermatitis (hydrocortisone, triamcinolone acetonide), rosacea (metronidazole), and seborrheic dermatitis (ketoconazole). Myristyl nicotinate was found to be compatible with each of the drugs examined when formulated together and also was shown to be photocompatible with retinoic acid. Our results suggest that the combination of myristyl nicotinate with these drugs is a feasible therapeutic development strategy.Keywords
This publication has 10 references indexed in Scilit:
- A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skinExperimental Dermatology, 2007
- Biochemistry of human skin—our brain on the outsideChemical Society Reviews, 2005
- Developing Topical Prodrugs for Skin Cancer Prevention2005
- Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitisInternational Journal of Dermatology, 2005
- Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitisBritish Journal of Dermatology, 2004
- Short-Term Glucocorticoid Treatment Compromises Both Permeability Barrier Homeostasis and Stratum Corneum Integrity: Inhibition of Epidermal Lipid Synthesis Accounts for Functional AbnormalitiesJournal of Investigative Dermatology, 2003
- Harmful effects of UVA on the structure and barrier function of engineered human cutaneous tissuesInternational Journal of Radiation Biology, 1999
- A review of skin ageing and its medical therapyBritish Journal of Dermatology, 1996
- Functional assessment of the stratum corneum under the influence of oral aromatic retinoid (etretinate) in guinea-pigs and humans. Comparison with topical retinoic acid treatmentBritish Journal of Dermatology, 1992
- Decreased stratum corneum cerarnides in atopic individuals—a pathobiochemical factor in xerosis?British Journal of Dermatology, 1988